Aldeyra Therapeutics Inc. buy marge
Start price
28.09.18
/
50%
€12.09
Target price
30.07.19
€17.14
Performance (%)
-58.96%
End price
30.07.19
€4.96
Summary
This prediction ended on 30.07.19 with a price of €4.96. The BUY prediction by marge for Aldeyra Therapeutics Inc. performed very badly with a performance of -58.96%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aldeyra Therapeutics Inc. | 5.300% | 5.300% | -10.112% | -82.931% |
| iShares Core DAX® | 2,55 % | -0,11 % | 15,00 % | 49,60 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % | 30,95 % | 80,87 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % | 49,70 % | 60,37 % |
| iShares S&P 500 | 1,93 % | -0,52 % | 24,88 % | 60,00 % |
Comments by marge for this prediction
In the thread Aldeyra Therapeutics Inc. diskutieren
marge stimmt der Buy-Einschätzung von stratec zu
marge stimmt am 28.09.2018 der Buy-Einschätzung von stratec mit dem Kursziel 19$ zu.
Überschrift: Aldeyra multiple trials are set to read out in the second half of the year
(Vom Mitglied beendet)